Patricia Kienle, BSPHARM, MPA, FASHP, discusses how and why compounding pharmacies should work with interdisciplinary teams on issues of patient safety.
Patricia Kienle, BSPHARM, MPA, FASHP, discusses how and why compounding pharmacies should work with interdisciplinary teams on patient safety. This video was filmed at the 2019 American Society of Health-System Pharmacists (ASHP) Summer Meetings & Exhibition in Boston.
Patricia Kienle, BSPHARM, MPA, FASHP: I think there's a couple of issues that need to be identified for a pharmacy to oversee that whole sterile compounding piece. Part of it is the nonhazardous drug that you do, but what you have to remember is that 797 also deals with hazardous drugs. The guts of that information is in USP 800, but it's also in 797. So if you're taking over infusion practices that include oncology, for example, you have to be sure that you're complying with both 797 and 800. The details of that are going to be very familiar to pharmacy, probably not so familiar to other clinicians—nursing and physician practices, for example—so the pharmacy needs to be the one who oversees that whole point and identifies the practical ways that we can best take care of patients.